AI Portfolio Summary
In 2026 Q1, PFIZER INC maintained a portfolio of 19 distinct positions. The most significant new addition to the portfolio was AGOMAB THERAPEUTICS , which now represents 0.34% of the total fund value. Conversely, PFIZER INC completely exited their position in AN2 THERAPEUTICS INC.
Total Positions
19
Quarter
2026 Q1
Top Holding
ORIC (24.1%)
Top 10 Concentration
96.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-19 of 19
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 24.14% | 18.60% |
#1
Prev: #1
|
6.5 | -595,943 | -11.1% |
P
S
|
4,780,401 | $57,651,636 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 20.85% | 12.76% |
#2
3
Prev: #5
|
6.5 | no change | no change |
P
S
|
22,032,040 | $49,792,410 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
ARVN
ARVINAS INC
|
Healthcare | 14.63% | 17.34% |
#3
1
Prev: #2
|
6.0 | no change | no change |
P
S
|
3,457,815 | $34,923,932 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
CELC
CELCUITY INC
|
Healthcare | 13.13% | 14.74% |
#4
1
Prev: #3
|
5.0 | -53,754 | -15.4% |
P
S
|
295,652 | $31,345,025 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 7.05% | 6.58% |
#5
1
Prev: #6
|
3.8 | -131,109 | -4.4% |
P
S
|
2,838,913 | $16,834,754 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 5.00% | 13.48% |
#6
2
Prev: #4
|
3.0 | no change | no change |
P
S
|
1,875,000 | $11,934,375 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
PYXS
PYXIS ONCOLOGY ...
|
Healthcare | 3.86% | 3.42% |
#7
Prev: #7
|
2.5 | no change | no change |
P
S
|
7,032,770 | $9,212,929 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
CRBU
CARIBOU BIOSCIE...
|
Healthcare | 3.50% | 3.15% |
#8
Prev: #8
|
2.4 | no change | no change |
P
S
|
4,690,431 | $8,348,967 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
SPRO
SPERO THERAPEUT...
|
Healthcare | 2.31% | 2.33% |
#9
2
Prev: #11
|
1.9 | no change | no change |
P
S
|
2,362,348 | $5,504,271 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 1.77% | 2.41% |
#10
Prev: #10
|
1.7 | no change | no change |
P
S
|
505,645 | $4,232,249 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
CRDF
CARDIFF ONCOLOG...
|
Healthcare | 1.57% | 2.87% |
#11
2
Prev: #9
|
1.6 | no change | no change |
P
S
|
2,411,575 | $3,737,941 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 0.84% | 0.54% |
#12
1
Prev: #13
|
1.3 | no change | no change |
P
S
|
953,834 | $2,003,051 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
NXTC
NEXTCURE INC
|
Healthcare | 0.64% | 0.95% |
#13
1
Prev: #12
|
0.8 | -4,292 | -2.7% |
P
S
|
153,354 | $1,535,074 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
N/A
AGOMAB THERAPEU...
|
—
|
Unknown | 0.34% | — |
#14
Prev: #—
|
3.6 | 75,000 | no change |
NEW
|
75,000 | $813,750 | — | 13F Filing | 2026-03-31 | 2026-05-12 | ||
|
QTTB
Q32 BIO INC
|
Healthcare | 0.31% | 0.39% |
#15
1
Prev: #14
|
0.1 | -176,159 | -63.4% |
P
S
|
101,618 | $736,731 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
BOLT
BOLT BIOTHERAPE...
|
Healthcare | 0.06% | 0.07% |
#16
Prev: #16
|
1.0 | no change | no change |
P
S
|
31,305 | $137,116 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
DNA
GINKGO BIOWORKS...
|
Healthcare | 0.01% | 0.01% |
#17
Prev: #17
|
1.0 | no change | no change |
P
S
|
2,928 | $17,363 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
SENS
SENSEONICS HLDG...
|
Healthcare | 0.01% | 0.01% |
#18
Prev: #18
|
1.0 | no change | no change |
P
S
|
2,171 | $14,242 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 0.00% | 0.34% |
Sold All 😨
(Was: #15) |
0.0 | -715,295 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-12 |
Showing 1-19 of 19 holdings